Optimal treatment allocation and study duration for trials with discrete-time survival endpoints

DOI10.1016/j.jspi.2012.11.006zbMath1257.62105OpenAlexW1976422621MaRDI QIDQ1937208

Mirjam Moerbeek, Katarzyna Jóźwiak

Publication date: 28 February 2013

Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jspi.2012.11.006

zbMATH Keywords

survival analysiscost functionoptimal designsdiscrete-time longitudinal dataallocation ratio

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Generalized linear models (logistic models) (62J12)

Related Items (2)

Optimal designs for discrete-time survival models with random effects ⋮ D‐optimal designs for a continuous predictor in longitudinal trials with discrete‐time survival endpoints

Cites Work

• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• Cost-effective designs for trials with discrete-time survival endpoints
• Maximind-optimal designs for binary longitudinal responses
• Efficiency of Balanced Treatment Allocation for Survival Analysis
• An Introduction to Optimal Designs for Social and Biomedical Research
• Sample Sizes for Clinical Trials
• Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
• On Robust and Efficient Designs for Risk Estimation in Epidemiological Studies
• Sample Size Calculations in Clinical Research
• Survival Analysis

This page was built for publication: Optimal treatment allocation and study duration for trials with discrete-time survival endpoints